☰

Victoria Blaho - Publications

Affiliations: 
Pathology and Lab Medicine Weill Cornell Medical College, New York, NY, United States 
Tree Info Similar researchers PubMed Report error

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Subbaramaiah K, Howe LR, Bhardwaj P, Du B, Gravaghi C, Yantiss RK, Zhou XK, Blaho VA, Hla T, Yang P, Kopelovich L, Hudis CA, Dannenberg AJ. Retraction: Obesity Is Associated With Inflammation and Elevated Aromatase Expression in the Mouse Mammary Gland. Cancer Prevention Research (Philadelphia, Pa.). 15: 413. PMID 35652231 DOI: 10.1158/1940-6207.CAPR-22-0202  0.405
2019 Obinata H, Kuo A, Wada Y, Swendeman S, Liu CH, Blaho VA, Nagumo R, Sato K, Izumi T, Hla T. Identification of ApoA4 as a sphingosine 1-phosphate chaperone in ApoM- and albumin-deficient mice. Journal of Lipid Research. PMID 31462513 DOI: 10.1194/Jlr.Ra119000277  0.781
2019 Ban Y, Dong W, Zhang L, Zhou T, Altiti AS, Ali K, Mootoo DR, Blaho VA, Hla T, Ren Y, Ma X. Abrogation of Endogenous Glycolipid Antigen Presentation on Myelin-Laden Macrophages by D-Sphingosine Ameliorates the Pathogenesis of Experimental Autoimmune Encephalomyelitis. Frontiers in Immunology. 10: 404. PMID 30941120 DOI: 10.3389/Fimmu.2019.00404  0.442
2019 Chun J, Kihara Y, Jonnalagadda D, Blaho VA. Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other Disorders. Annual Review of Pharmacology and Toxicology. 59: 149-170. PMID 30625282 DOI: 10.1146/annurev-pharmtox-010818-021358  0.383
2019 Blaho V, Chun J, Frantz A, Hla T, Jones D, Jonnalagadda D, Kihara Y, Mizuno H, Moolenaar W, Mpamhanga C, Spiegel S, Tan V, Yung YC. Lysophospholipid (LPA) receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database Iuphar/Bps Guide to Pharmacology Cite. 2019. DOI: 10.2218/gtopdb/f36/2019.4  0.587
2019 Blaho V, Chun J, Jonnalagadda D, Kihara Y, Mizuno H, Mpamhanga C, Spiegel S, Tan V. Lysophospholipid (S1P) receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database Iuphar/Bps Guide to Pharmacology Cite. 2019. DOI: 10.2218/gtopdb/f135/2019.4  0.496
2018 Blaho VA, Chun J. 'Crystal' Clear? Lysophospholipid Receptor Structure Insights and Controversies. Trends in Pharmacological Sciences. 39: 953-966. PMID 30343728 DOI: 10.1016/j.tips.2018.08.006  0.442
2017 Swendeman SL, Xiong Y, Cantalupo A, Yuan H, Burg N, Hisano Y, Cartier A, Liu CH, Engelbrecht E, Blaho V, Zhang Y, Yanagida K, Galvani S, Obinata H, Salmon JE, et al. An engineered S1P chaperone attenuates hypertension and ischemic injury. Science Signaling. 10. PMID 28811382 DOI: 10.1126/Scisignal.Aal2722  0.695
2015 Galvani S, Sanson M, Blaho VA, Swendeman SL, Conger H, Dahlbäck B, Kono M, Proia RL, Smith JD, Hla T. HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation. Science Signaling. 8: ra79. PMID 26268607 DOI: 10.1126/Scisignal.Aaa2581  0.801
2015 Blaho VA, Galvani S, Engelbrecht E, Liu C, Swendeman SL, Kono M, Proia RL, Steinman L, Han MH, Hla T. HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation. Nature. 523: 342-6. PMID 26053123 DOI: 10.1038/Nature14462  0.765
2015 Galvani S, Sanson M, Blaho VA, Swendeman SL, Conger H, Dahlbäck B, Kono M, Proia RL, Smith JD, Hla T. HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation Science Signaling. 8. DOI: 10.1126/scisignal.aaa2581  0.778
2014 Garris CS, Blaho VA, Hla T, Han MH. Sphingosine-1-phosphate receptor 1 signalling in T cells: trafficking and beyond. Immunology. 142: 347-53. PMID 24597601 DOI: 10.1111/Imm.12272  0.625
2014 Blaho VA, Hla T. An update on the biology of sphingosine 1-phosphate receptors. Journal of Lipid Research. 55: 1596-1608. PMID 24459205 DOI: 10.1194/Jlr.R046300  0.669
2013 Garris CS, Wu L, Acharya S, Arac A, Blaho VA, Huang Y, Moon BS, Axtell RC, Ho PP, Steinberg GK, Lewis DB, Sobel RA, Han DK, Steinman L, Snyder MP, et al. Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. Nature Immunology. 14: 1166-72. PMID 24076635 DOI: 10.1038/Ni.2730  0.663
2011 Blaho VA, Hla T. Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors. Chemical Reviews. 111: 6299-320. PMID 21939239 DOI: 10.1021/Cr200273U  0.657
2011 Oo ML, Chang SH, Thangada S, Wu MT, Rezaul K, Blaho V, Hwang SI, Han DK, Hla T. Engagement of S1P₁-degradative mechanisms leads to vascular leak in mice. The Journal of Clinical Investigation. 121: 2290-300. PMID 21555855 DOI: 10.1172/Jci45403  0.758
2011 Subbaramaiah K, Howe LR, Bhardwaj P, Du B, Gravaghi C, Yantiss RK, Zhou XK, Blaho VA, Hla T, Yang P, Kopelovich L, Hudis CA, Dannenberg AJ. Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prevention Research (Philadelphia, Pa.). 4: 329-46. PMID 21372033 DOI: 10.1158/1940-6207.Capr-10-0381  0.446
2010 Thangada S, Khanna KM, Blaho VA, Oo ML, Im DS, Guo C, Lefrancois L, Hla T. Cell-surface residence of sphingosine 1-phosphate receptor 1 on lymphocytes determines lymphocyte egress kinetics. The Journal of Experimental Medicine. 207: 1475-83. PMID 20584883 DOI: 10.1084/Jem.20091343  0.778
Show low-probability matches.